Victoza not to be used in Type 1 diabetes with insulin
Novo Nordisk has been carrying out trials of Type 2 drug, Victoza (liraglutide)
with insulin in people with Type 1 diabetes. However, although HbA1cs were
not better or worse, the number of severe hypos was greater and there was
a higher rate of symptomatic hypoglycaemia in people taking Victoza and
insulin compared to those taking insulin alone. So in August 2015, Novo Nordisk
announced that it is not going to apply for approval for use of this combination.
IDDT Note: We have received quite a few concerned calls from people with Type
1 diabetes who have been prescribed Victoza in addition to their insulin. This
confirms that Victoza is not approved for use in people with Type 1.